Effects of dual renin-angiotensin system blockade on proteinuria in a hypertensive black African HIV-infected patient

Effects of dual renin-angiotensin system blockade on proteinuria in a hypertensive black African HIV-infected patient

Case study

Bibliographic Details
Main Authors:	Claudio Ucciferri, Katia Falasca, Paola Mancino, Roberto Tommasi, Alfonso Tatasciore, Jacopo Vecchiet
Format:	Article
Language:	English
Published:	AOSIS 2011-04-01
Series:	Southern African Journal of HIV Medicine
Online Access:	https://sajhivmed.org.za/index.php/hivmed/article/view/213

Similar Items

Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension
by: Timothy WR Doulton, et al.
Published: (2009-12-01)

Induction with ribavirin in a relapsing patient with chronic HCV hepatitis
by: Claudio Ucciferri, et al.
Published: (2012-05-01)

Cystatin C and cardiovascular risk in HIV infected patients
by: Vecchiet Jacopo, et al.
Published: (2010-05-01)

Induction with ribavirin in a relapsing patient with chronic HCV hepatitis
by: Claudio Ucciferri, et al.

USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS
by: Paola Mancino, et al.
Published: (2010-03-01)

USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS
by: Claudio Ucciferri, et al.
Published: (2010-02-01)

The dual blockade of the renin-angiotensin system in Internal Medicine: after ONTARGET trial
by: F. Rondoni, et al.
Published: (2013-05-01)

Review: Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment
by: Niels Holmark Andersen, et al.
Published: (2001-09-01)

Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
by: Yan-Huan Feng, et al.
Published: (2016-01-01)

PIDOTIMOD IN PAUCISYMPTOMATIC SARS-CoV2 INFECTED PATIENTS
by: Claudio Ucciferri, et al.
Published: (2020-06-01)

Cardiac toxicity associated with HCV direct antiviral agents
by: Claudio Ucciferri, et al.
Published: (2018-10-01)

Review: Combining renin-angiotensin-aldosterone system blockade with diuretic therapy for treatment of hypertension
by: Joseph G Motwani
Published: (2002-06-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Overview of Regulation of the Renin–Angiotensin–Aldosterone System
by: Akira Nishiyama, et al.
Published: (2010-01-01)

Renin–angiotensin system blockade for the risk of cancer and death
by: Jian Shen, et al.
Published: (2016-07-01)

Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin–angiotensin–aldosterone system among patients with obesity and proteinuria
by: Enrique Morales, et al.
Published: (2015-11-01)

Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin–angiotensin–aldosterone system among patients with obesity and proteinuria
by: Enrique Morales, et al.
Published: (2015-11-01)

Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor β1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat
by: Arie Erman, et al.
Published: (2004-09-01)

Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
by: Nancy Houston Miller
Published: (2010-01-01)

Review: The renin-angiotensin-aldosterone system, blockade and diabetic nephropathy
by: Norman K Hollenberg
Published: (2001-03-01)

Role of proteinuria in the regulation of renal renin-angiotensin system components in unilateral proteinuric rats
by: Leo E Deelman, et al.
Published: (2003-03-01)

Treatment of hypertension during the COVID-19 pandemic: questions about the blockade of the renin-angiotensin-aldosterone system
by: S. G. Kanorskiy
Published: (2021-04-01)

The renin-angiotensin system in obesity hypertension
by: Arya M Sharma, et al.
Published: (2001-03-01)

COVID-19 in a patient with SISTEMIC sclerosis: The role of ruxolitinib
by: Claudio Ucciferri, et al.
Published: (2021-09-01)

Renal Kallikrein Activation and Renoprotection after Dual Blockade of Renin-Angiotensin System in Diet-Induced Diabetic Nephropathy
by: Xia Zou, et al.
Published: (2015-01-01)

Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
by: Luz Lozano-Maneiro, et al.
Published: (2015-11-01)

Blockade of the renin-angiotensin-aldosterone system and renal protection in diabetes mellitus
by: Hans-Henrik Parving
Published: (2000-03-01)

Efficacy of eplerenone added to renin-angiotensin blockade in elderly hypertensive patients: the Jichi-Eplerenone Treatment (JET) study
by: Yuichiro Yano, et al.
Published: (2011-09-01)

Effects of exercise on central aortic pressure before and after treatment with renin–angiotensin system blockade in patients with hypertension
by: Peter S Lacy, et al.
Published: (2015-12-01)

Renoprotection in Type 2 diabetes: blockade of the renin-angiotensin system with angiotensin II receptor blockers
by: Pauline A Swift, et al.
Published: (2001-09-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Characteristics and Usefulness of the Direct Renin Inhibitor Aliskiren
by: Atsuhiro Ichihara, et al.
Published: (2010-01-01)

Urinary cytokine profiles according to the site of blockade of the renin-angiotensin system in nephrectomized rats
by: Nilo César do Vale Baracho, et al.

Review: Preventing End-Stage Renal Disease in Diabetic Patients — Dual Blockade of the Renin-Angiotensin System (Part II)
by: Peter Karl Jacobsen
Published: (2005-06-01)

COMPARATIVE EFFICACY OF BLOCKADE OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM WITH COMBINATIONS OF ALISKIREN AND AMLODIPINE, RAMIPRIL AND AMLODIPINE IN PATIENTS WITH ESSENTIAL HYPERTENSION
by: E. Krutikov, et al.
Published: (2017-12-01)

Review: Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension
by: Boris Gojanovic, et al.
Published: (2008-03-01)

Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension – study protocol for a randomized controlled trial
by: Elizabeth do Espirito Santo Cestário, et al.
Published: (2018-02-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Mineralocorticoid-Receptor Blockers Exert Antihypertensive and Renoprotective Effects Independently of the Renin–Angiotensin System
by: Akira Nishiyama, et al.
Published: (2010-01-01)

Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy
by: Claudio Ucciferri, et al.
Published: (2016-07-01)

Long term effect of telmisartan in HIV-positive male patients with high blood pressure
by: Claudio Ucciferri, et al.
Published: (2015-11-01)

Emerging Therapies for Diabetic Nephropathy Patients: Beyond Blockade of the Renin-Angiotensin System
by: Bassem Y. Tanios, et al.
Published: (2012-10-01)

Renin-Angiotensin System Blockade Associated with Statin Improves Endothelial Function in Diabetics
by: Ronaldo Altenburg Gismondi, et al.
Published: (2015-01-01)

Cannot write session to /tmp/vufind_sessions/sess_9nd67k74ku4epchskblcmv1ia0